As of June 10, 2025, Mitrabara Adiperdana Tbk PT's estimated intrinsic value ranges from $959.36 to $5300.53 per share, depending on the valuation methodology applied.
| Valuation Method | Fair Value (USD) | Implied Upside/Downside |
|---|---|---|
| Discounted Cash Flow (10Y) | $2826.35 | +59.7% |
| Discounted Cash Flow (5Y) | $2891.07 | +63.3% |
| Dividend Discount Model (Multi-Stage) | $959.36 | -45.8% |
| Dividend Discount Model (Stable) | $1175.14 | -33.6% |
| Earnings Power Value | $5300.53 | +199.5% |
Is Mitrabara Adiperdana Tbk PT (MBAP.JK) undervalued or overvalued?
With the current market price at $1770.00, the stock appears to be significantly undervalued.
Intrinsic value represents the "true" worth of a company based on its fundamentals rather than market sentiment. We've employed multiple methodologies to triangulate Mitrabara Adiperdana Tbk PT's intrinsic value, including:
The cost of capital is a critical factor in valuation models, representing the required return for investors.
| WACC Component | Low | High |
|---|---|---|
| Long-term bond rate | 6.6% | 7.1% |
| Equity market risk premium | 7.9% | 8.9% |
| Adjusted beta | 0.99 | 1.07 |
| Cost of equity | 14.4% | 17.1% |
| Cost of debt | 5.0% | 5.0% |
| Tax rate | 22.7% | 24.4% |
| Debt/Equity ratio | 0.04 | 0.04 |
| After-tax WACC | 14.0% | 16.6% |
Our DCF model projects cash flows over 5-year and 10-year horizons, with the following key assumptions:
| DCF Model | Fair Value | Enterprise Value | % from Terminal Value |
|---|---|---|---|
| 5-Year Growth | $0 | $107M | 52.2% |
| 10-Year Growth | $0 | $102M | 24.6% |
| 5-Year EBITDA | $0 | $102M | 49.8% |
| 10-Year EBITDA | $0 | $103M | 25.3% |
The DDM values a company based on its expected future dividend payments. We used two approaches:
EPV assesses a company's value based on its current normalized earnings power, assuming no growth.
| EPV Component | Value |
|---|---|
| Normalized Earnings | $44M |
| Discount Rate (WACC) | 16.6% - 14.0% |
| Enterprise Value | $265M - $313M |
| Net Debt | $(111)M |
| Equity Value | $376M - $424M |
| Outstanding Shares | 1,227M |
| Fair Value | $0 - $0 |
| Selected Fair Value | $5300.53 |
| Metric | Value |
|---|---|
| Market Capitalization | $2172268M |
| Enterprise Value | $369974M |
| Trailing P/E | 8.13 |
| Forward P/E | 8.00 |
| Trailing EV/EBITDA | 3.50 |
| Current Dividend Yield | 0.02% |
| Dividend Growth Rate (5Y) | -38.40% |
| Debt-to-Equity Ratio | 0.04 |
To determine the most reliable intrinsic value estimate, we weigh each valuation method based on:
| Valuation Method | Weight | Weighted Value |
|---|---|---|
| Discounted Cash Flow (10Y) | 30% | $847.90 |
| Discounted Cash Flow (5Y) | 25% | $722.77 |
| Dividend Discount Model (Multi-Stage) | 20% | $191.87 |
| Dividend Discount Model (Stable) | 15% | $176.27 |
| Earnings Power Value | 10% | $530.05 |
| Weighted Average | 100% | $2468.87 |
Based on our comprehensive valuation analysis, Mitrabara Adiperdana Tbk PT's weighted average intrinsic value is $2468.87, which is approximately 39.5% above the current market price of $1770.00.
Key investment considerations:
Given these factors, we believe Mitrabara Adiperdana Tbk PT is currently significantly undervalued with the potential for long-term appreciation based on the company's growth trajectory and financial strength.